Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.
about
Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1Mutator pathways unleashed by epigenetic silencing in human cancerFrequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patientsIdentification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approachEvidence of a founder BRCA1 mutation in ScotlandThe BRCA2 gene product functionally interacts with p53 and RAD51A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer familiesBRCA1 interacts with components of the histone deacetylase complexBRCA1 and BRCA2 mutations in central and southern Italian patients.BRCA1 Zinc RING Finger Domain Disruption Alters Caspase Response in Ovarian Surface Epithelial Cells.The expanding role of yeast in cancer research and diagnosis: insights into the function of the oncosuppressors p53 and BRCA1/2Phosphopeptide interactions with BRCA1 BRCT domains: More than just a motifStructural consequences of a cancer-causing BRCA1-BRCT missense mutationPARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directionsHereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?BRCT domain-containing protein TopBP1 functions in DNA replication and damage responseRole of direct interaction in BRCA1 inhibition of estrogen receptor activityBRCA1 associates with processive RNA polymerase IIIdentification of residues required for the interaction of BARD1 with BRCA1Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian PopulationBARD1 participates with BRCA1 in homology-directed repair of chromosome breaksNovel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish familiesSelected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) methodPathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.Design and synthesis of a 3'-O-allyl photocleavable fluorescent nucleotide as a reversible terminator for DNA sequencing by synthesisConstitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells.The cancer-predisposing mutation C61G disrupts homodimer formation in the NH2-terminal BRCA1 RING finger domain.Digital detection of genetic mutations using SPC-sequencing.The functions of breast cancer susceptibility gene 1 (BRCA1) product and its associated proteins.German family study on hereditary breast-ovarian cancerBRCA1 mutations in a selected series of breast/ovarian cancer patients.Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sitesThe 12 base pair duplication/insertion alteration could be a regulatory mutation.Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer familiesUsing gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genesHOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.A novel human striated muscle RING zinc finger protein, SMRZ, interacts with SMT3b via its RING domain.Identification of collaborative driver pathways in breast cancer.
P2860
Q22008789-81597151-C623-4D66-ACF1-E35EC100CEB1Q22242850-7A8543DA-3154-45E3-8A68-10B158812126Q24170410-BB527478-EBA2-49B6-9853-059C7C077834Q24290680-0DBD54FE-3107-4374-AB33-9A1B2BB79772Q24649433-BD06614C-7302-4309-839D-FA42001ECC3EQ24650406-AE8AC0F3-C1A9-44B7-99BE-941A9C0F23FEQ24680760-20F84B63-AD38-4630-BC3D-B2E58EFBD64CQ24684925-68824E71-4784-4D3C-8BAB-6E01183BA8FFQ24791292-65DAB593-E09D-4D5A-8101-FA166F5618B6Q24796229-F7E5F6E5-43AC-4DC4-A0C8-23F198F21AFFQ26851138-7D64B077-13F8-4EF2-8CC9-B5979596100DQ26999072-D461B50D-C9CA-4B6A-A138-2B09ECFD6C6DQ27639943-EDCE47C6-CF1F-4284-B6CA-4E6CA8716658Q28071345-599188D9-F891-43B7-87D6-1CE97423B53BQ28085485-6A11C99E-7412-4511-B052-82768B5400E8Q28200771-27799BF6-70B5-4781-87C5-1BB7174CAFA3Q28204456-18175C29-79F4-421D-8610-40DAE39E60A2Q28204666-BA9B4868-714F-4720-B956-38E116A4D882Q28214378-2026047B-811E-4BE3-BEAE-2E888F85395CQ28389268-46D686AD-7122-43EE-A0F5-A3E3826CD33EQ28609933-9F203CCB-F704-4B9A-A569-D3D1B2CE8997Q28763558-83C7AEB9-E505-4F70-A7F5-1E28F3DF1694Q30386593-572F90B5-EB19-440C-8C77-6B428B668A7FQ30717784-49725AA5-1057-41A0-B015-709AF8456D46Q31159863-3159262D-53FD-4758-98B7-939910AD0968Q31159921-2E4C6965-9B3B-4256-9AFC-E7F2C945642BQ31864260-F326DB8B-C072-421A-9C13-9854CD309F0BQ32076900-65F85FFF-29A1-4461-B8EB-C8D373EE0254Q33197458-771CCA0A-EB7B-48D3-8B50-E8282D0CD82AQ33589502-8AE3799A-280F-4BC0-9BCE-105406A08D7EQ33677619-00F2CFE3-3A39-461E-BC7E-B1C9F120C230Q33677746-52D85110-1903-4EF8-9111-2867730F3615Q33677871-9CA4510A-1E30-485F-9DD8-CD279FFE7DFDQ33679166-2734C01E-A2C2-4026-9431-B104C402C264Q33679692-545BB758-6F33-4E30-A736-51002961AB02Q33680173-1B483C30-9E82-4303-A04B-9B6F91CB6BC5Q33815755-E4579F41-6083-4252-95BF-B88E2143FFB6Q33900686-268CB864-E6AC-4F36-A238-C2D11257713DQ33941031-AC9352DA-9F7C-4E19-8C14-23FBCB878F03Q33953601-DDC64FF0-8FB5-4115-8694-BC86FC00086E
P2860
Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Confirmation of BRCA1 by analy ...... varian cancer in ten families.
@ast
Confirmation of BRCA1 by analy ...... varian cancer in ten families.
@en
Confirmation of BRCA1 by analy ...... varian cancer in ten families.
@nl
type
label
Confirmation of BRCA1 by analy ...... varian cancer in ten families.
@ast
Confirmation of BRCA1 by analy ...... varian cancer in ten families.
@en
Confirmation of BRCA1 by analy ...... varian cancer in ten families.
@nl
prefLabel
Confirmation of BRCA1 by analy ...... varian cancer in ten families.
@ast
Confirmation of BRCA1 by analy ...... varian cancer in ten families.
@en
Confirmation of BRCA1 by analy ...... varian cancer in ten families.
@nl
P2093
P356
P1433
P1476
Confirmation of BRCA1 by analy ...... varian cancer in ten families.
@en
P2093
Friedman LS
Ostermeyer EA
P2888
P304
P356
10.1038/NG1294-399
P407
P577
1994-12-01T00:00:00Z
P5875
P6179
1043977123